Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Babay Pharma from Sint-Joost-ten-Node, company number BE1010855608, closed financial year 2025 with a result of € 75,707 after tax. For that financial year Babay Pharma recorded a gross margin of € 113,391 and equity of € 107,624. Compared with financial year 2024, the result moved from € 1,917 to € 75,707. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 27, 2026.
€ 107,624
▲ 237% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 75,707
▲ € 73,790 vs 2024
Profit after tax over the fiscal year.
€ 24,003
▲ € 18,963 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 77,624.
Debts at end 2025
€ 80,605
▼ 19% vs 2024
€ 21,384 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 36,654
▲ 28% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 22,114
▲ 268% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 15,027 | € 113,391 | ▲ € 98,364 |
| Profit after taxes | € 1,917 | € 75,707 | ▲ € 73,790 |
| Equity | € 31,917 | € 107,624 | ▲ 237% |
| Total debts | € 137,791 | € 139,373 | ▲ 1% |
| Cash | € 5,040 | € 24,003 | ▲ € 18,963 |
| Retained profit | € 1,917 | € 77,624 | ▲ € 75,707 |
| Bank debt | € 99,500 | € 80,605 | ▼ 19% |
| Balance sheet total | € 169,708 | € 246,996 | ▲ 46% |
By gross margin, Babay Pharma ranks 7th of 9 companies with main activity “Detailhandel in farmaceutische producten” in Sint-Joost-ten-Node that publish figures (fiscal year 2025).
Key figures of Babay Pharma, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Babay Pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Babay Pharma?
What happened at Babay Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 75,707 (▲ € 73,790 vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Sint-Joost-ten-Node. KBO
In short
From € 1,917 profit in 2024 to € 75,707 profit in 2025.
Paid € 19,876 in corporate taxes since 2024.
Best year ever: 2025, with € 75,707 profit.
Establishments
Establishment units
Physical locations of this company
Merinosstraat 38
1210 Sint-Joost-ten-Node
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Sint-Joost-ten-Node
Same main activity (Detailhandel in farmaceutische producten), 9 active companies in Sint-Joost-ten-Node, largest first.
€ 402,964 gross margin · 2025
€ 324,194 gross margin · 2025
€ 237,120 gross margin · 2025
€ 200,394 gross margin · 2025
€ 183,803 gross margin · 2024
€ 116,358 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- BABAY Bochra(oprichter) 90%
- MOUMEN Abdelhafidh(oprichter) 10%
Details
- Company number
- 1010.855.608
- VAT number
- BE 1010.855.608
- Registered office
- Merinosstraat 38, 1210 Sint-Joost-ten-Node
- Names & denominations
- Babay Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 June 2024
- Peppol
- Active · Active since 19 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten